Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC) — HULPUTC

Enterocutaneous Fistula Clinical Trial

Official title:
A Phase II Clinical Trial to Study the Feasibility and Safety of Stromal Vascular Derived From Adipose Tissue for the Treatment of Enterocutaneous Fistula

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine safety of Stromal Vascular Fraction (SVF) for the treatment of enterocutaneous fistula.

Clinical Trial Description

SF-12 Test ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01584713
Study type	Interventional
Source	Instituto de Investigación Hospital Universitario La Paz
Contact	Mariano Garcia Arranz
Phone	+34912071022
Email	mgarciaa.hulp@salud.madrid.org
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	December 2011
Completion date	December 2013

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04577456` - Chyme Reinfusion for Type 2 Intestinal Failure	N/A
	Completed	`NCT03302598` - Assessment of Relation Between Recurrence of Enterocutaneous Fistula and Preoperative C-reactive Protein Level After Complete Surgical Repair	N/A